Amrutanjan Health Care Limited
NSE:AMRUTANJAN.NS
781.25 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2012 Q4 | 2012 Q3 | 2012 Q2 | 2012 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 837.36 | 1,002.17 | 1,169.937 | 993.116 | 778.63 | 1,002.169 | 976.455 | 1,107.193 | 709.542 | 1,061.575 | 1,106.959 | 1,103.82 | 782.115 | 927.211 | 1,000.97 | 921.117 | 466.185 | 585.594 | 827.54 | 748.077 | 445.959 | 838.818 | 702.694 | 620.49 | 357.684 | 746.797 | 629.427 | 563.046 | 316.957 | 695.495 | 591.144 | 555.454 | 577.53 | 360.014 | 288.003 | 141.016 |
| Cost of Revenue
| 594.54 | 510.97 | 565.722 | 509.139 | 406.102 | 510.968 | 419.39 | 539.541 | 349.887 | 500.51 | 468.045 | 498.09 | 338.03 | 405.032 | 401.198 | 382.311 | 213.311 | 225.646 | 361.373 | 339.534 | 244.159 | 383.366 | 332.609 | 293.114 | 179.843 | 333.946 | 259.474 | 235.071 | 153.347 | 303.109 | 203.873 | 192.519 | 275.414 | 135.808 | 129.363 | 60.943 |
| Gross Profit
| 242.82 | 491.2 | 604.215 | 483.977 | 372.528 | 491.201 | 557.065 | 567.652 | 359.655 | 561.065 | 638.914 | 605.73 | 444.085 | 522.179 | 599.772 | 538.806 | 252.874 | 359.948 | 466.167 | 408.543 | 201.8 | 455.452 | 370.085 | 327.376 | 177.841 | 412.851 | 369.953 | 327.975 | 163.61 | 392.386 | 387.271 | 362.935 | 302.116 | 224.206 | 158.64 | 80.073 |
| Gross Profit Ratio
| 0.29 | 0.49 | 0.516 | 0.487 | 0.478 | 0.49 | 0.57 | 0.513 | 0.507 | 0.529 | 0.577 | 0.549 | 0.568 | 0.563 | 0.599 | 0.585 | 0.542 | 0.615 | 0.563 | 0.546 | 0.453 | 0.543 | 0.527 | 0.528 | 0.497 | 0.553 | 0.588 | 0.583 | 0.516 | 0.564 | 0.655 | 0.653 | 0.523 | 0.623 | 0.551 | 0.568 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 11.952 | 0 | 0 | 0 | 11.283 | 0 | 0 | 0 | 8.707 | 0 | 0 | 0 | 10.502 | 0 | 0 | 0 | 10.583 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 135.528 | 43.033 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27.273 | 0 | 0 | 0 | 24.364 | 0 | 0 | 0 | 24.413 | 0 | 0 | 0 | 24.412 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 95.744 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 87.678 | 152.017 | 136.291 | 170.524 | 65.396 | 71.353 | 198.802 | 156.742 | 98.919 | 264.669 | 197.235 | 174.246 | 93.214 | 281.993 | 155.412 | 82.975 | 35.56 | 170.428 | 176.459 | 112.312 | 55.827 | 169.3 | 163.516 | 99.698 | 61.265 | 104.955 | 146.269 | 57.333 | 32.889 | 122.71 | 119.762 | 88.317 | 48.186 | 77.849 | 27.641 | 13.754 |
| SG&A
| 223.206 | 195.05 | 136.291 | 170.524 | 65.396 | 71.353 | 198.802 | 156.742 | 98.919 | 291.942 | 197.235 | 174.246 | 93.214 | 306.357 | 155.412 | 82.975 | 35.56 | 194.841 | 176.459 | 112.312 | 55.827 | 193.712 | 163.516 | 99.698 | 61.265 | 104.955 | 146.269 | 57.333 | 32.889 | 122.71 | 215.506 | 88.317 | 48.186 | 77.849 | 27.641 | 13.754 |
| Other Expenses
| 44.52 | 49.506 | 37.639 | 39.475 | 36.863 | 48.194 | 36.775 | 30.324 | 30.125 | -101.556 | 31.983 | 42.851 | 27.389 | -71.974 | 25.448 | 40.487 | 20.456 | -55.491 | 22.615 | 18.642 | 15.547 | -43.398 | 15.993 | 15.418 | 13.201 | 203.627 | 16.442 | 135.857 | 12.837 | 195.251 | 0 | 162.876 | 186.645 | 91.575 | 80.162 | 59.691 |
| Operating Expenses
| 223.206 | 375.51 | 404.248 | 431.101 | 314.856 | 375.513 | 448.648 | 423.575 | 337.031 | 366.882 | 391.449 | 384.329 | 307.764 | 400.197 | 343.36 | 264.954 | 186.27 | 273.849 | 362.331 | 305.455 | 225.884 | 265.804 | 310.493 | 247.871 | 211.308 | 308.582 | 306.498 | 193.19 | 191.252 | 317.961 | 267.452 | 251.193 | 234.831 | 169.424 | 107.803 | 73.445 |
| Operating Income
| 19.614 | 115.69 | 237.606 | 92.351 | 57.672 | 164.882 | 145.192 | 174.401 | 22.624 | 193.22 | 247.465 | 221.401 | 136.321 | 140.786 | 281.86 | 273.852 | 66.604 | 86.099 | 103.836 | 103.088 | -24.084 | 189.648 | 59.592 | 79.505 | -33.467 | 104.269 | 63.455 | 134.785 | -27.642 | 74.425 | 84.522 | 111.742 | 67.285 | 54.782 | 50.837 | 6.628 |
| Operating Income Ratio
| 0.023 | 0.115 | 0.203 | 0.093 | 0.074 | 0.165 | 0.149 | 0.158 | 0.032 | 0.182 | 0.224 | 0.201 | 0.174 | 0.152 | 0.282 | 0.297 | 0.143 | 0.147 | 0.125 | 0.138 | -0.054 | 0.226 | 0.085 | 0.128 | -0.094 | 0.14 | 0.101 | 0.239 | -0.087 | 0.107 | 0.143 | 0.201 | 0.117 | 0.152 | 0.177 | 0.047 |
| Total Other Income Expenses Net
| 43.874 | 48.02 | -0.542 | -0.297 | 36.624 | -0.172 | -0.159 | -0.195 | 29.881 | 6.973 | 31.685 | 42.16 | 26.541 | -3.671 | -0.429 | 40.035 | 20.008 | 20.285 | 22.148 | 18.139 | 15.028 | 12.318 | 15.993 | 15.061 | 13.022 | -0.274 | 35.103 | -0.641 | 12.192 | -0.653 | 34.631 | -1.027 | -9.604 | -5.589 | -4.831 | -4.768 |
| Income Before Tax
| 63.488 | 164.71 | 237.064 | 92.054 | 94.296 | 164.71 | 145.033 | 174.206 | 52.505 | 200.193 | 279.15 | 263.561 | 162.862 | 137.115 | 281.431 | 313.887 | 86.612 | 106.384 | 125.984 | 121.227 | -9.056 | 201.966 | 75.585 | 94.566 | -20.445 | 103.995 | 98.558 | 134.144 | -15.45 | 73.772 | 119.153 | 110.715 | 57.681 | 49.193 | 46.006 | 1.86 |
| Income Before Tax Ratio
| 0.076 | 0.164 | 0.203 | 0.093 | 0.121 | 0.164 | 0.149 | 0.157 | 0.074 | 0.189 | 0.252 | 0.239 | 0.208 | 0.148 | 0.281 | 0.341 | 0.186 | 0.182 | 0.152 | 0.162 | -0.02 | 0.241 | 0.108 | 0.152 | -0.057 | 0.139 | 0.157 | 0.238 | -0.049 | 0.106 | 0.202 | 0.199 | 0.1 | 0.137 | 0.16 | 0.013 |
| Income Tax Expense
| 17.332 | 37.76 | 62.569 | 23.562 | 24.148 | 37.758 | 37.926 | 46.556 | 15.865 | 53.134 | 73.372 | 65.083 | 42.288 | 34.827 | 71.575 | 78.399 | 22.34 | 27.465 | 31.056 | 37.193 | -2.008 | 59.811 | 20.326 | 27.995 | -6.436 | 54.117 | 32.848 | 42.88 | -1.341 | 44.895 | 26.333 | 39.455 | 25.363 | 15.509 | 13.882 | -1.18 |
| Net Income
| 46.156 | 136.59 | 174.495 | 68.492 | 70.148 | 126.952 | 107.107 | 127.65 | 36.64 | 147.059 | 205.778 | 198.478 | 120.574 | 102.288 | 209.856 | 235.488 | 64.272 | 78.919 | 94.928 | 84.034 | -7.048 | 142.71 | 52.867 | 64.927 | -15.362 | 57.161 | 64.336 | 91.264 | -15.105 | 26.279 | 92.82 | 71.26 | 32.318 | 33.684 | 32.124 | 3.04 |
| Net Income Ratio
| 0.055 | 0.136 | 0.149 | 0.069 | 0.09 | 0.127 | 0.11 | 0.115 | 0.052 | 0.139 | 0.186 | 0.18 | 0.154 | 0.11 | 0.21 | 0.256 | 0.138 | 0.135 | 0.115 | 0.112 | -0.016 | 0.17 | 0.075 | 0.105 | -0.043 | 0.077 | 0.102 | 0.162 | -0.048 | 0.038 | 0.157 | 0.128 | 0.056 | 0.094 | 0.112 | 0.022 |
| EPS
| 1.6 | 4.35 | 6.04 | 2.36 | 2.4 | 4.35 | 3.67 | 4.37 | 1.26 | 5.08 | 7.05 | 6.79 | 4.12 | 3.5 | 7.18 | 8.06 | 2.2 | 2.7 | 3.25 | 2.87 | -0.24 | 4.88 | 1.81 | 2.22 | -0.53 | 1.96 | 2.2 | 3.19 | -0.51 | 0.9 | 3.18 | 2.44 | 1.11 | 1.15 | 1.1 | 0.1 |
| EPS Diluted
| 1.6 | 4.35 | 6.04 | 2.36 | 2.39 | 4.34 | 3.66 | 4.36 | 1.25 | 5.07 | 7.03 | 6.77 | 4.12 | 3.5 | 7.18 | 8.06 | 2.2 | 2.7 | 3.25 | 2.87 | -0.24 | 4.88 | 1.81 | 2.22 | -0.53 | 1.96 | 2.2 | 3.19 | -0.51 | 0.9 | 3.18 | 2.44 | 1.11 | 1.15 | 1.1 | 0.1 |
| EBITDA
| 35.487 | 162.368 | 253.371 | 107.895 | 108.455 | 177.98 | 158.333 | 189.607 | 63.419 | 215.131 | 288.22 | 272.298 | 172.914 | 150.686 | 290.301 | 323.214 | 96.541 | 117.313 | 138.676 | 134.396 | -0.042 | 207.635 | 83.725 | 102.977 | -13.081 | 113.492 | 86.826 | 144.849 | -8.986 | 79.201 | 92.834 | 119.875 | 83.424 | 63.026 | 57.678 | 12.671 |
| EBITDA Ratio
| 0.042 | 0.162 | 0.217 | 0.109 | 0.139 | 0.178 | 0.162 | 0.171 | 0.089 | 0.203 | 0.26 | 0.247 | 0.221 | 0.163 | 0.29 | 0.351 | 0.207 | 0.2 | 0.168 | 0.18 | -0 | 0.248 | 0.119 | 0.166 | -0.037 | 0.152 | 0.138 | 0.257 | -0.028 | 0.114 | 0.157 | 0.216 | 0.144 | 0.175 | 0.2 | 0.09 |